FindTrial
Sign In

Effect of Pre-operative nasal mupirocin in preventing port site infection after laparoscopic surgery at RIMS Ranchi

Pre-operative nasal Mupirocin prophylaxis to prevent the risk of Port-site infection in patients undergoing laparoscopic surgery at RIMS Ranchi A Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109620
Enrollment
154
Registered
2026-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L039- Cellulitis and acute lymphangitis,unspecified

Interventions

Intervention1: Preoperative nasal mupirocin: Patient will receive intranasal mupirocin ointment, applied twice daily for two days prior to surgery Control Intervention1: Standard care: Patients will r

Sponsors

Rajendra Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing laparoscopic surgery at RIMS, Ranchi.

Exclusion criteria

Exclusion criteria: Patients allergic to Mupirocin. Pregnant females. Immunocompromised patients or patients on steroids and other Immunosuppressant drugs. Patients with comorbidities like diabetes mellitus, liver cirrhosis, renal failure.

Design outcomes

Primary

MeasureTime frame
Incidence of Port site infection following laparoscopic surgeryTimepoint: Within 30 days post operatively—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactShivam Kumar Jha

Rajendra Institute of Medical Sciences

drnmpekka@gmail.com9431358260

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026